A COMPUTER-SIMULATION MODEL FOR COST-EFFECTIVENESS ANALYSIS OF CARDIOVASCULAR-DISEASE PREVENTION

被引:32
|
作者
JOHANNESSON, M
HEDBRANT, J
JONSSON, B
机构
[1] Department of Health and Society, Linköping University, Linköping
[2] Center of Technology Transfer, Linköping Institute of Technology, Linköping
来源
MEDICAL INFORMATICS | 1991年 / 16卷 / 04期
关键词
COST-EFFECTIVENESS ANALYSIS; COMPUTER SIMULATIONS; MEDICAL DECISION-MAKING; CARDIOVASCULAR DISEASE;
D O I
10.3109/14639239109067657
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
In this paper a computer simulation model for cost-effectiveness analysis of cardiovascular disease prevention is presented. Cost-effectiveness analysis makes it possible to compare the cost-effectiveness of different interventions in order to maximize the health effects for a given amount of resources. The computer simulation model was written in Turbo-Pascal to be used on an IBM-PC-compatible. The model was based on the 8-year logistic multivariate risk equations for CHD and stroke from the Framingham Heart Study, but the regression coefficients can easily be changed if local data exist. The main advantages with the model are that it is easy to use, transparent, and flexible. The model was mainly developed for scientific purposes, but should be useful also for educational purposes and clinical decision analysis. The modelling approach used should also be useful in many other medical areas.
引用
收藏
页码:355 / 362
页数:8
相关论文
共 50 条
  • [1] Prevention and treatment of cardiovascular disease in Ethiopia: a cost-effectiveness analysis
    Tolla, Mieraf Taddesse
    Norheim, Ole Frithjof
    Memirie, Solomon Tessema
    Abdisa, Senbeta Guteta
    Ababulgu, Awel
    Jerene, Degu
    Bertram, Melanie
    Strand, Kirsten
    Verguet, Stephane
    Johansson, Kjell Arne
    [J]. COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2016, 14
  • [2] Prevention and treatment of cardiovascular disease in Ethiopia: a cost-effectiveness analysis
    Mieraf Taddesse Tolla
    Ole Frithjof Norheim
    Solomon Tessema Memirie
    Senbeta Guteta Abdisa
    Awel Ababulgu
    Degu Jerene
    Melanie Bertram
    Kirsten Strand
    Stéphane Verguet
    Kjell Arne Johansson
    [J]. Cost Effectiveness and Resource Allocation, 14
  • [3] Smoking cessation for primary prevention of cardiovascular disease: A cost-effectiveness analysis
    Kinderen, AJD
    Oh, F
    De Laet, C
    [J]. VALUE IN HEALTH, 2004, 7 (06) : 692 - 693
  • [4] Towards Effective Cost-Effectiveness Analysis in Atherosclerotic Cardiovascular Disease Prevention
    Kajinami, Kouji
    [J]. CIRCULATION JOURNAL, 2018, 82 (04) : 954 - 955
  • [5] COST-EFFECTIVENESS OF NOVEL DRUGS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE
    Silbernagel, Gunther
    Bilger, Marcel
    [J]. ATHEROSCLEROSIS, 2024, 395
  • [6] Primary prevention of cardiovascular disease: a cost-effectiveness comparison
    Franco, O
    De Laet, C
    Der Kinderen, A
    Peeters, A
    Bonneux, L
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 : 122 - 122
  • [7] Primary prevention of cardiovascular disease: Cost-effectiveness comparison
    Franco, Oscar H.
    Kinderen, Arno J. der
    De Laet, Chris
    Peeters, Anna
    Bonneux, Luc
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2007, 23 (01) : 71 - 79
  • [8] Primary prevention of cardiovascular disease: A cost-effectiveness comparison
    Franco, OH
    De Laet, C
    Kinderen, AD
    Peeters, A
    Bonneux, L
    [J]. CIRCULATION, 2004, 110 (17) : 802 - 802
  • [9] Cost-effectiveness of antihypertensives in the primary prevention of cardiovascular disease
    Duran, O. H. Franco
    Kinderen, A. Der
    Steyerberg, E.
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 : 578 - 578
  • [10] Maximising the effectiveness and cost-effectiveness of cardiovascular disease prevention in the general population
    Tonkin, Andrew M.
    Boyden, Andrew N.
    Colagiuri, Stephen
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2009, 191 (06) : 300 - 302